Bridgewater Associates’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,675
Closed -$111K 672
2024
Q4
$111K Sell
11,675
-29,067
-71% -$294K ﹤0.01% 690
2024
Q3
$458K Sell
40,742
-41,521
-50% -$441K ﹤0.01% 698
2024
Q2
$823K Sell
82,263
-5,857
-7% -$59.5K ﹤0.01% 696
2024
Q1
$1.01M Sell
88,120
-14,702
-14% -$125K 0.01% 570
2023
Q4
$750K Sell
102,822
-7,489
-7% -$59K ﹤0.01% 669
2023
Q3
$1M Buy
110,311
+19,942
+22% +$239K 0.01% 602
2023
Q2
$1.1M Buy
90,369
+1,733
+2% +$19.3K 0.01% 558
2023
Q1
$1.1M Buy
88,636
+4,899
+6% +$90.1K 0.01% 552
2022
Q4
$1.61M Sell
83,737
-20,510
-20% -$434K 0.01% 566
2022
Q3
$1.96M Sell
104,247
-1,590
-2% -$32.7K 0.01% 567
2022
Q2
$1.91M Buy
105,837
+9,051
+9% +$147K 0.01% 693
2022
Q1
$1.55M Buy
96,786
+18,181
+23% +$327K 0.01% 732
2021
Q4
$1.92M Sell
78,605
-43,688
-36% -$1.03M 0.01% 469
2021
Q3
$2.85M Sell
122,293
-8,672
-7% -$210K 0.02% 378
2021
Q2
$3.59M Buy
+130,965
New +$3.73M 0.02% 393

Other funds holding AHCO

Bridgewater Associates's AHCO Position: Q1 2025 in Review

Bridgewater Associates sold out of AdaptHealth (AHCO) in Q1 2025, closing a stake of 11,675 shares — an estimated $111K sold.

Bridgewater Associates first reported a position in AHCO in Q2 2021 and held it in 15 quarters. The position peaked at $3.59M in Q2 2021. 226 funds tracked by Wall St. Rank hold AHCO as of Q1 2025.

  • Bridgewater Associates reported no remaining AdaptHealth position as of Q1 2025 after selling out during the quarter.
  • Bridgewater Associates sold 11,675 AdaptHealth shares in Q1 2025, an estimated $111K.
  • Bridgewater Associates first reported a position in AdaptHealth in Q2 2021 and held it in 15 quarters.
  • Bridgewater Associates's AdaptHealth position peaked at $3.59M in Q2 2021.
  • 226 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2025.

Based on Bridgewater Associates's 13F filing for Q1 2025, filed 14 May 2025.